Breast cancer risk and methylenetetrahydrofolate reductase polymorphism

Breast Cancer Research and Treatment

Volumn 77, Issue 3, 2003, Pages 217-223

  Semenza, Jan C ^a   Delfino, Ralph J ^b   Ziogas, Argyrios ^b   Anton Culver, Hoda ^b  

^a PORTLAND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol; Breast cancer; Folate; Methylenetetrahydrofolate reductase; MTHFR; Postmenopausal

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; CANCER CONTROL; CANCER RISK; CELL DIVISION; CELL REGENERATION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DNA SYNTHESIS; ENZYME POLYMORPHISM; FEMALE; FOLATE METABOLISM; GENE INTERACTION; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METHYLATION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SINGLE BLIND PROCEDURE;

BREAST NEOPLASMS; CALIFORNIA; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; HUMANS; MENOPAUSE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RISK FACTORS;

EID: 0037320923     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021843019755     Document Type: Article

References (20)

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990
2. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994
3. Nass SJ, Herman JG, Gabrielson E: Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res 60: 4346-4348, 2000
4. Frosst P, Blom HJ, Milos R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113, 1995
5. Delfino RJ, Sinha R, Smith C: Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis 21: 607-615, 2000
6. Botto LD, Yang: 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151: 862-877, 2000
7. Dupont WD, Parl FF, Hartmann WH: Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71: 1258-1265, 1993
8. Chen J, Giovannucci E, Kelsey K: A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56: 4862-4864, 1996
9. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N: Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48: 536-545, 1991
10. Henderson BE, Ross R, Bernstein L: Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 48: 246-253, 1988
11. Semenza JC, Ziogas A, Largent J, Peel D, Anton-Culver H: Gene-environment interactions in renal cell carcinoma. Am J Epidemiol 153: 851-859, 2001
12. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M: Methylenetetra-hydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8: 513-518, 1999
13. Ma J, Stampfer MJ, Giovannucci E: Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102, 1997
14. Chen J, Giovannucci E, Kelsey K: A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56: 4862-4864, 1996
15. Potter JD: Colorectal cancer: molecules and populations. J Natl Cancer Inst 91: 916-932, 1999
16. Skibola CF, Smith MT, Kane E: Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96: 12810-12815, 1999
17. Viel A, Dall'Agnese L, Simone F: Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. Br J Cancer 75: 1105-1110, 1997
18. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J: Germ line polymorphisms in cytochrome-P450 1A1 and methylenetetrahydrofolate reductase (C4887CYP1A1) (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18: 2307-2311, 1997
19. Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E, Friedman E: Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer 36: 2313-2316, 2000
20. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC: A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 260: 652-656, 1988